Key highlights
Filter
Period
Filter by
recent search
Showing: 1 – 05 of 22 Financial Results
Ipsen delivers solid H1 2023 results and upgrades its full-year guidance
The performance in the first half of the year is reflected in today’s upgrade to our full-year guidance. We look forward to more milestones and further expansion of the pipeline over time through additional external-innovation transactions. I am confident, as…
Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance
Paris (France), 27 April 2023
Ipsen presents strong full-year 2022 results and guidance for 2023
Paris (France), 9 February 2023
Ipsen delivers strong sales growth in the first nine months of 2022 and confirms its full-year guidance
Paris (France), 27 October 2022
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022: